Locals have not forgotten them, so when Donald Trump talks about imposing 25 per cent tariffs on Canadian goods, and “America First,” Windsorites start reliving some nightmarish memories and harbour a ...
Presentations & Reports within the Investors section of the Company website ABOUT TFI INTERNATIONAL TFI International Inc. is a North American leader in the transportation and logistics industry, ...
TORONTO — Tesla Inc. says it is raising prices by up to $9,000 starting Feb. 1 on its Model 3 vehicle, the cheapest in its lineup. The company says it will also be raising prices on the Model Y, X and ...
The federal centre, known as Fintrac, identifies cash linked to money laundering and terrorism by sifting through millions of pieces of data annually from banks, insurance companies, securities ...
OTTAWA — Statistics Canada says retail sales in November were flat compared with October as gains in sales at motor vehicle and parts dealers and gasoline stations and fuel vendors offset lower sales ...
Apple Inc. and Alphabet Inc. were hit with United Kingdom antitrust investigations over concerns their dominance in mobile services is distorting the market and putting up barriers to entry for ...
Investors await Trump’s address to the World Economic Forum on Thursday, as well as U.S. jobless claims data, which may give a clue on the United States Federal Reserve ’s rate-cutting path. Lower ...
The Clean Technology Manufacturing Credit allows corporations to write off 30 per cent of machinery and has been passed into ...
The stubbornly high cost of living has many Canadians feeling anxious, stuck, and struggling to make ends meet, according to a new poll released today by Royal Bank of Canada (RBC).
Newly elected U.S. President Donald Trump has threatened to impose a 25-per-cent tariff on all goods from Canada. With that potential damage hanging over the economy, some argue the central bank will ...
Now, those pieces of legislation could be a target of the Trump administration — particularly the digital services tax that ...
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA ...